Ibrutinib monotherapy for relapse or refractory primary CNS lymphoma and primary vitreoretinal lymphoma: Final analysis of the phase II ‘proof-of-concept’ iLOC study by the Lymphoma study association (LYSA) and the French oculo-cerebral lymphoma (LOC) network

Authors: Soussain, C., Choquet, S., Blonski, M., Leclercq, D., Houillier, C., Rezai, K., Bijou, F., Houot, R., Boyle, E., Gressin, R., Nicolas-Virelizier, E., Barrie, M., Moluçon-Chabrot, C., Lelez, M.L., Clavert, A., Coisy, S., Leruez, S., Touitou, V., Cassoux, N., Daniau, M., Ertault de la Bretonnière, M., El Yamani, A., Ghesquières, H., Hoang-Xuan, K.

Source: In European Journal of Cancer August 2019 117:121-130

Lenalidomide in combination with intravenous rituximab (REVRI) in relapsed/refractory primary CNS lymphoma or primary intraocular lymphoma: a multicenter prospective ‘proof of concept’ phase II study of the French Oculo-Cerebral lymphoma (LOC) Network and the Lymphoma Study Association (LYSA)

Authors: Ghesquieres, H., Chevrier, M., Laadhari, M., Chinot, O., Choquet, S., Moluçon-Chabrot, C., Beauchesne, P., Gressin, R., Morschhauser, F., Schmitt, A., Gyan, E., Hoang-Xuan, K., Nicolas-Virelizier, E., Cassoux, N., Touitou, V., Le Garff-Tavernier, M., Savignoni, A., Turbiez, I., Soumelis, V., Houillier, C., Soussain, C. ^*

Source: In Annals of Oncology April 2019 30(4):621-628

Lymphome intraoculaire associé au lymphome primitif non hodgkinien du système nerveux central : expérience d’un centre tertiaire sur une durée de sept ans

Alternate Title: Intraocular lymphoma associated with primary malignant lymphoma of the central nervous system: Seven-year experience of a tertiary center (English)

Authors: Joubert, R., Bonnin, N., Kemeny, J.-L., Moluçon-Chabrot, C., Tournilhac, O., Bacin, F., Chiambaretta, F.

Source: In Journal Francais d'Ophtalmologie June 2015 38(6):559-566

A phase 1/2 trial of lenalidomide and dexamethasone in adult patients with refractory/relapsed acute lymphoblastic leukemia

Authors: Tavernier-Tardy, E., Cornillon, J., Molucon-Chabrot, C., Cahn, J. Y., Tinquaut, F., Bourmaud, A., Guyotat, D., Thomas, X.

Source: Hematology. 22(4):217-223

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100108361686.0x000001&indx=1&recIds=ETOCvdc_100108361686.0x000001

Gemtuzumab ozogamicin for treatment of acute myeloid leukemia

Authors: Brotelle, T., Lemal, R., Molucon-Chabrot, C., Bay, J.-O., Delaunay, J., Guieze, R.

Source: BULLETIN DU CANCER. 101(2):211-218

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN368254871&indx=1&recIds=ETOCRN368254871

Severe Aplastic Anemia Associated With Eosinophilic Fasciitis: Report of 4 Cases and Review of the Literature

Authors: de Masson, A., Bouaziz, J.-D., de Latour, R.P., Benhamou, Y., Molucon-Chabrot, C., Bay, J.-O., Laquerriere, A., Picquenot, J.-M., Michonneau, D., Leguy-Seguin, V.

Source: MEDICINE -BALTIMORE-. 92(2):69-81

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN338581669&indx=1&recIds=ETOCRN338581669

Major therapeutic advances and new perspectives in onco-hematology

Authors: Bay, J.-O., Guieze, R., Ravinet, A., Lemal, R., Xhaard, A., Bailly, S., Molucon-Chabrot, C., Hermet, E., Biau, J., Verrelle, P.

Source: BULLETIN DU CANCER. 100(6):587-600

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN334790914&indx=1&recIds=ETOCRN334790914

Histone deacetylase inhibitors in the treatment of hematological malignancies

Authors: Lemal, R., Ravinet, A., Molucon-Chabrot, C., Bay, J.-O., Guieze, R.

Source: BULLETIN DU CANCER. 98(8):867-878

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN299839113&indx=1&recIds=ETOCRN299839113

Feasibility of using intraperitoneal epinephrine and cisplatin in patients with advanced peritoneal carcinomatosis

Authors: Molucon-Chabrot, C., Isambert, N., Benoit, L., Zanetta, S., Fraisse, J., Guilland, J.-C., Royer, B., Monin-Baroille, P., Flesch, M., Fargeot, P.

Source: ANTICANCER DRUGS. 17(10):1211-1218

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN197599878&indx=1&recIds=ETOCRN197599878

Intérêt du dosage de l’haptoglobine pour juger de l’observance des patients PR traités par tocilizumab

Authors: Montagnon, P.Y., Fan, A., Chen Wa, C., Beauger, M., Couderc, M., Ladouce, F., Malochet-Guinamand, S., Moluçon-Chabrot, C., Pickering, M.E., Squercioni, B., Tournadre, A., Soubrier, M., Mathieu, S.

Source: In Revue du rhumatisme December 2023 90 Supplement 1:A120-A120

Suivi de l’utilisation de l’Eltrombopag en vie réelle en France à partir des données de l’Observatoire National de l’Insuffisance Médullaire (RIME) : étude REVEPI

Authors: Sicre De Fontbrune, F., Barraco, F., Dalle, J.H., Forcade, E., Terriou, L., Berceanu, A., Lebon, D., Thépot, S., Abraham, J., Fahd, M., Lioure, B., Contejean, A., Moluçon Chabrot, C., Leblanc, T., Leclerc-Teffahi, S., Affinito, S., Kamar, D., Havet, A., Bénard, S., Regis, P.L.

Source: In La revue de médecine interne December 2021 42 Supplement 2:A315-A315

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.